Pharmaceutical preparations based on infliximab for intravenous use

Summary

The procurement concerns the supply of pharmaceutical preparations based on infliximab for intravenous use in two lots. Tenderers must meet a minimum annual turnover requirement of EUR 1,500,000 for each lot, provide proof of registration with a medicines authority, and arrange a 5% tender guarantee. Tenders must be submitted electronically by 19 October 2026 at 11:00. Price accounts for 85% of the evaluation and the qualitative criterion for 15%.